Mannan-MOG35-55 Reverses Experimental Autoimmune Encephalomyelitis, Inducing a Peripheral Type 2 Myeloid Response, Reducing CNS Inflammation, and Preserving Axons in Spinal Cord Lesions.

Dagkonaki A, Avloniti M, Evangelidou M, Papazian I, Kanistras I, Tseveleki V, Lampros F, Tselios T, Jensen LT, Möbius W, Ruhwedel T, Androutsou ME, Matsoukas J, Anagnostouli M, Lassmann H, Probert L.

Open source

DOI
10.3389/fimmu.2020.575451
Published
2020-11-19
Container
Front Immunol
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2020.575451,
  title = {Mannan-MOG35-55 Reverses Experimental Autoimmune Encephalomyelitis, Inducing a Peripheral Type 2 Myeloid Response, Reducing CNS Inflammation, and Preserving Axons in Spinal Cord Lesions.},
  author = {Dagkonaki A and  Avloniti M and  Evangelidou M and  Papazian I and  Kanistras I and  Tseveleki V and  Lampros F and  Tselios T and  Jensen LT and  Möbius W and  Ruhwedel T and  Androutsou ME and  Matsoukas J and  Anagnostouli M and  Lassmann H and  Probert L.},
  year = {2020},
  journal = {Front Immunol},
  doi = {10.3389/fimmu.2020.575451},
  url = {https://doi.org/10.3389/fimmu.2020.575451}
}

RIS

TY  - JOUR
TI  - Mannan-MOG35-55 Reverses Experimental Autoimmune Encephalomyelitis, Inducing a Peripheral Type 2 Myeloid Response, Reducing CNS Inflammation, and Preserving Axons in Spinal Cord Lesions.
AU  - Dagkonaki A
AU  -  Avloniti M
AU  -  Evangelidou M
AU  -  Papazian I
AU  -  Kanistras I
AU  -  Tseveleki V
AU  -  Lampros F
AU  -  Tselios T
AU  -  Jensen LT
AU  -  Möbius W
AU  -  Ruhwedel T
AU  -  Androutsou ME
AU  -  Matsoukas J
AU  -  Anagnostouli M
AU  -  Lassmann H
AU  -  Probert L.
PY  - 2020
JO  - Front Immunol
DO  - 10.3389/fimmu.2020.575451
UR  - https://doi.org/10.3389/fimmu.2020.575451
ER  - 

APA

A, D., M, A., M, E., I, P., I, K., V, T., F, L., T, T., LT, J., W, M., T, R., ME, A., J, M., M, A., H, L., & L., P. (2020). Mannan-MOG35-55 Reverses Experimental Autoimmune Encephalomyelitis, Inducing a Peripheral Type 2 Myeloid Response, Reducing CNS Inflammation, and Preserving Axons in Spinal Cord Lesions.. Front Immunol. https://doi.org/10.3389/fimmu.2020.575451

Source records